Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
about
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host DiseaseEngineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo.The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation.Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammationPartial netrin-1 deficiency aggravates acute kidney injuryCombination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.Cellular function and molecular structure of ecto-nucleotidases.Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection.Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemiaTransgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantationEcto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestineIntestinal ischemia-reperfusion injury alters purinergic receptor expression in clinically relevant extraintestinal organs.Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury.NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury.Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes.Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury.Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.Hypoxia signaling during intestinal ischemia and inflammation.The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.8-BuS-ATP derivatives as specific NTPDase1 inhibitors.The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture.Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation.Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertension.CD39-adenosinergic axis in renal pathophysiology and therapeutics.
P2860
Q28068647-758C2786-27FC-4B63-82F0-A6AF53E60F5CQ33316622-CB00D1C8-D370-48E3-B380-ACCCF488DCD7Q33685912-2393646E-FA63-4485-AED7-EC78CC1844BEQ33830064-60CBED86-F952-46A2-BE73-3ED804DA69E2Q33916670-9B785B76-ADCB-4615-BFB6-197E8BB3FA6EQ34020021-67E2C84C-9F56-429A-864F-51DF3D7D492FQ34031794-C4923B0A-7601-47C0-B102-DD33A8CF4CEEQ34087391-C8D5142C-AD35-45C6-93EE-7AF606DD5686Q34703746-1D2F6358-644D-4FB2-BDFA-71D08D84D1D4Q34769236-6D511B53-9AFB-41AB-9EB2-07DDFC0F1597Q35085768-2C353AD4-A679-4105-8CB6-9022EC75673AQ35202450-1C482B26-C348-49F4-BFC9-4875ACA63427Q35574518-7410F165-339E-43E9-B9DD-DB20497BCB39Q35632965-B38865C9-4E71-4E17-ABE1-4568E9347FD6Q36174033-2BB88D36-8B33-4575-A241-B412E08630F5Q36350059-B8CBB4BB-A38F-4C31-908C-C758DD464571Q36516823-4D7E7BE8-B5CE-4011-8C45-1F028F2BAD99Q36571085-380A2412-AF8D-4D5C-959A-5A83D32E9018Q36779378-993A6017-A8DC-4CCF-B83B-144CE64FCF12Q36804999-B52D74E3-F221-4D91-BA53-6BEEE1D41AC0Q36961254-23F56871-59B6-4F33-9B19-330B9340770DQ36999844-99A619E4-8722-4CEE-A969-78051DF48A4DQ37039131-2B8D3E29-1CC3-49F8-9042-72A5526EB087Q37135540-131F73D9-ACEB-4372-A60B-35F5C6363F6BQ37248599-9BC47994-B95E-424E-9454-46B3ADFBCB5CQ37297986-61CB0438-CC49-481C-B44C-C784460F1CEFQ37373524-2D056BDF-18BA-4CD3-AA0D-47A818454EA6Q38063159-FC89D6FE-A94C-47AF-9775-B86BDAC0087CQ39989919-5F4C4D7B-0211-4715-8192-1BCE9FE90340Q40121574-839803EC-49BD-4BA3-85F4-1824A93E8348Q40766858-15EEAD65-9D48-41D4-A445-B4EDF6EA23DCQ41149629-8C00555E-94B8-42C4-B45A-6E4D4550CBC3Q42199760-EF532E52-D876-4D23-B24B-6019BECBEF24Q43102079-E825B67D-097F-45FA-AB82-DC10FBAEA31CQ43140401-ADD8DC00-7666-420D-8078-B07F6AAAA699Q47298425-5F383301-4996-4217-9AE0-EDEB2C81204FQ47655859-DF7B02A9-77EF-4EB5-9B62-172E3089499B
P2860
Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Beneficial effects of CD39/ect ...... l ischemia-reperfusion injury.
@en
Beneficial effects of CD39/ect ...... l ischemia-reperfusion injury.
@nl
type
label
Beneficial effects of CD39/ect ...... l ischemia-reperfusion injury.
@en
Beneficial effects of CD39/ect ...... l ischemia-reperfusion injury.
@nl
prefLabel
Beneficial effects of CD39/ect ...... l ischemia-reperfusion injury.
@en
Beneficial effects of CD39/ect ...... l ischemia-reperfusion injury.
@nl
P2093
P356
P1476
Beneficial effects of CD39/ect ...... l ischemia-reperfusion injury.
@en
P2093
Elzbieta Kaczmarek
Jean Sévigny
Jonathan B Kruskal
Keiichi Enjyoji
Masato Imai
Olaf Guckelberger
Simon C Robson
Xiao Feng Sun
P304
P356
10.1160/TH03-06-0373
P577
2004-03-01T00:00:00Z